Executive Summary

References
[1.a] Fahy, E., S. Subramaniam, H.A. Brown, C.K. Glass, A.H. Merrill, Jr., R.C. Murphy, C.R. Raetz, D.W. Russell, Y. Seyama, W. Shaw, T. Shimizu, F. Spener, G. van Meer, M.S. Vannieuwenhze, S.H. White, J. Witztum, and E.A. Dennis (2005) A comprehensive classification system for lipids. J. Lipid Res. 46, 839-861.

[1.b] idem: (2005) Eur. J. Lipid Sci. Technol. 107, 337-364

[2] Varfolomeyev, S., Efremenko, E., Beletskaya, I., Bertini, I., Blackburn, G.M., Bogdanov, A., Cunin, R., Eichler, J., Galaev, I., Gladyshev, V., O’Hagan, D., Haertle, T., Jarv, J., Karyakin, A., Kurochkin, I., Mikolajczyk, M., Poroikov, V., Sakharov, I., Spener, F., Voyer, N., and Wild, J. (2005) Postgenomic chemistry (IUPAC Technical Report). Pure Appl. Chem. 77, 1641–1654.

[3] Spener F. (2005) Lipidomics and consequences: a new classification system for lipids. Eur. J. Lipid Sci. Technol. 107, 277-278.

[4] van Meer, G. (2005) Cellular Lipidomics. EMBO J. 24, 3159-3165.

[5] Schmitz, G., Liebisch, G., Langmann, T. (2006) Lipidomic strategies to study structural and functional defects of ABC-transporters in cellular lipid trafficking. FEBS Lett. 580, 5597-5610.

[6] van Meer, G., Leeflang, B.R., Liebisch, G,. Schmitz, G., Goni, F.M. (2007) The European lipidomics initiative: enabling technologies. Methods Enzymol. 2007;432, 213-232.

[7] White paper on 'Enabling technologies for studying the genome, proteome and cytome of the lipidome.' to be published in Wikipedia format on the LEP website.

[8] Spener F. (2005) European Commission funds lipidomics project. Eur. J. Lipid Sci. Technol. 107, 1-2.

[9] Griffiths, W. (2006) Why steroidomics in brain? Eur. J. Lipid Sci. Technol. 108, 707–708.

[10] Helms, B. (2006) Host-Pathogen interactions: Lipids grease the way. Eur. J. Lipid Sci. Technol. 108, 895–897.

[11] Spener, F., Kohlwein, S.D., and Schmitz, G. (2006) Lipid droplets and lamellar bodies – from innocent bystanders to prime targets of lipid research for combating human diseases. Eur. J. Lipid Sci. Technol. 108, 541-543.

[12] Spener, F., Zechner, R., and Borlak, J. (2006) Is lipotoxicity an oxymoron? Eur. J. Lipid Sci. Technol. 108, 625-627.

[13] van Meer, G. (2006) How do sphingolipids and lipid rafts relate to pathology? Eur. J. Lipid Sci. Technol. 108, 799–801.

[14] van Meer, G. and Spener, F. (Co-Chairs), Leeflang, B.R. (Secretary), Beisiegel, U., Bougnoux, P., Goñi, F., Griffiths, W., Hartmann, T., Helms, B., Hoekstra, D., Julià-Sapé, M., Larijani, B., Moschetta, A., Mouritsen, O.G., Norata, G.D., Payrastre, B., Record, M., Schmitz, G., Simons, K., Tselepis, A., Vaz, W., Vigh, L., Voelker, D.R., Wakelam, M.J.O., and Wanders, R.J.A. (2008) Structural Medicine II: the Importance of Lipidomics for Health and Disease, European Science Foundation Policy Briefing, in press.

[15] van Meer, G. (main proposer), Malhotra, V., Marsh, M., Simons, K., van der Goot, G., Warren, G. (2008) Membrane Architecture and Dynamics (EuroMEMBRANE), EuroCORE theme proposal. Call to be launched in spring 2008.

[16] Helms, B. and van Meer, G., eds. (2006) Lipidome and Disease. FEBS Letters Special Issue. FEBS Lett. 580, 5429-5610.

[17] Winckler, L. (2005) Lipidomics. Laborjournal 12, 20-23.

[18] Hillyer, C.D. (2006) Lipidomics: taking it one lipid at a time. Inform 17, 206-208.

LSSG-CT-2004-013032

ELIfe

European Lipidomics Initiative: Shaping the Life Sciences

Instrument: Specific Support Action

Thematic Priority: FP6-2003-LIFESCIHEALTH-II; LSH-2003-3-6